Alicia Zavala-Ayala

  • Citations Per Year
Learn More
BACKGROUND AND OBJECTIVE To describe 'radiation-first' combination treatment with a non-invasive, low-voltage x-ray irradiation system followed by as needed ranibizumab for neovascular age-related macular degeneration (AMD). STUDY DESIGN AND METHODS Phase I study of non-invasive, low-voltage 16 Gy x-ray irradiation delivered in three beams via the(More)
PURPOSE To describe the 12-month safety and efficacy outcomes of 16 or 24 Gy radiation using low-voltage x-ray irradiation in conjunction with intravitreal ranibizumab for neovascular age-related macular degeneration (AMD). DESIGN Prospective, phase I, open-label, nonrandomized uncontrolled safety study. METHODS setting: Institutional. study population:(More)
  • 1